PolyNovo Limited (FRA:MFJ)

Market Cap	485.87M
Revenue (ttm)	71.85M
Net Income (ttm)	7.38M
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	65.87
Forward PE	57.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	206
Open	0.6500
Previous Close	0.6600
Day's Range	0.6500 - 0.6500
52-Week Range	0.4800 - 1.3400
Beta	n/a
RSI	52.90
Earnings Date	Feb 22, 2026

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to tre...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1998
• Employees: 301
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MFJ

Financial Performance

In 2025, PolyNovo's revenue was 128.70 million, an increase of 24.67% compared to the previous year's 103.23 million. Earnings were 13.21 million, an increase of 151.17%.

Financial numbers in AUD